DRAM (DRAM1) Rabbit Polyclonal Antibody

SKU
TA306391
Rabbit Polyclonal DRAM Antibody
  $640.00
2 Weeks*
Bulk/Customize
Specifications
Specifications
Product Data
Application IF, IHC, WB
Recommended Dilution WB: 0.5 - 2 ug/mL, ICC: 2.5 ug/mL, IF: 20 ug/mL
Reactivity Human, Mouse, Rat
Antibody Host Rabbit
Isotype IgG
Clonality Polyclonal
Immunogen DRAM antibody was raised against a 16 amino acid synthetic peptide from near the amino terminus of human DRAM. The immunogen is located within amino acids 30 - 80 of DRAM.
Buffer PBS containing 0.02% sodium azide.
Purification Affinity chromatography purified via peptide column
Conjugation Unconjugated
Storage Store at -20°C as received.
Stability Stable for 12 months from date of receipt.
Shipping Blue Ice
Gene Name DNA damage regulated autophagy modulator 1
Database Link
Background Damage-regulated autophagy modulator (DRAM) is a p53 target gene encoding a lysosomal protein that induces autophagy, a process that degrades cytosolic proteins and organelles. It has been suggested that activation of DRAM by p53 is simultaneous to the activation by p53 of one or more proapoptotic genes such as PUMA, Bax, etc., and that the signaling pathways regulated by these genes together promote a full cell death response. By itself, DRAM cannot induce apoptosis, but the fact that it is inactivated in certain cancers highlights the importance of DRAM and suggests that autophagy may play a more important role in cancer than initially suspected. At least two different isoforms of DRAM are known to exist.
Synonyms DRAM
Reference Data
Protein Categories Intracellular Proteins, Membrane Proteins
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling
Feng, Cheng, Jin et al
Acta Histochem (2022) 124 (3), 151874 DOI: 10.1016/j.acthis.2022.151874
Cited by 2
AI Summary: OriGene’s anti-DRAM1 antibody (Cat.no: TA306391) was used for Western blot analysis to assess DRAM1 protein expression in clear cell renal cell carcinoma cells, supporting the study’s investigation into DRAM1’s tumor suppressor role.
Snippet: The blots were incubated with primary antibody against DRAM1 (Origene Technologies, Inc, USA, Cat.no:TA306391, 1:1000 dilution), BAX (Proteintech, USA, Cat. no:
WB IHC FC
Showing 1-1 of 1 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products